16
Last reporting period 31 Dec, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.64
Exchange
XHKG - Hong Kong Exchange
3.6 B
Last period Cash and equivalents ,CNY
182%
Cash and equivalents has increased in 5 years
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Consun Pharmaceutical
Company Analysis
1681.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
1681.HK financial analysis by Eyestock methodology
Valuation
1681.HK valuation using historical relative method
Statements
1681.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
1681.HK dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Consun Pharmaceutical`s Cash and equivalents for the period ended 2023-12-31 are 3.6 B CNY
